Clearance of hepatitis G viremia in a human immunodeficiency virus- positive patient by high-activity antiretroviral therapy

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1332-1333

  Toyoda, Hidenori ^a   Fukuda, Yoshihide ^a   Takamatsu, Junki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR;

ADULT; ARTICLE; CASE REPORT; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS REPLICATION;

ADULT; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; INDINAVIR; RNA, VIRAL; VIREMIA;

EID: 0033497396     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313480     Document Type: Article

References (9)

1. 1. Lipsky JJ. Antiretroviral drugs for AIDS. Lancet 1996;348:800-3.
2. 2. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
3. 3. Tacke M, Kiyosawa K, Stark K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997;349:318-20.
4. 4. Nakao H, Okamoto H, Fukuda M, et al. Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. Virology 1997;233:43-50.
5. 5. Kato T, Mizokami M, Nakano T, et al. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus. J Med Virol 1998;55:109-17.
6. 6. Thomas DL, Vlahov D, Alter HJ, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998;177:539-42.
7. 7. Devereux H, Sabin CA, Kinson Z, et al. Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients. J Med Virol 1998; 56:316-20.
8. 8. Goubau P, Liu H-F, Goderniaux E, Burtonboy G. Influence of CD4 lymphocyte counts on GB virus C/hepatitis G virus carriership in HIV-positive individuals. J Med Virol 1999;57:367-9.
9. 9. Tanaka T, Hess G, Schlueter V, Zdunek D, Tanaka S, Kohara M. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelop 2 protein antibody. J Med Virol 1999;57:370-5.